Published in Ann Rheum Dis on April 01, 1992
Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann Rheum Dis (1995) 1.46
Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. Br J Pharmacol (2009) 1.25
Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis (1993) 1.12
Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal. Biochem J (2000) 1.00
Vitamin E in the primary prevention of rheumatoid arthritis: the Women's Health Study. Arthritis Rheum (2008) 0.91
T-cell recognition of lipid peroxidation products breaks tolerance to self proteins. Immunology (1999) 0.88
Extra-articular manifestations of rheumatoid arthritis: risk factors for serious gastrointestinal events. Ann Rheum Dis (1993) 0.80
2nd International meeting on synovium cell biology, physiology and pathology. Canterbury, United Kingdom, 21-23 September 1994. Proceedings and abstracts. Ann Rheum Dis (1995) 0.75
Inhibition of poly(ADP-ribose) formation by 4-hydroxynonenal in primary cultures of rabbit synovial fibroblasts. Biochem J (1996) 0.75
Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem (1980) 5.86
1958 REVISION of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum (1959) 4.55
Identification of 4-hydroxynonenal as a cytotoxic product originating from the peroxidation of liver microsomal lipids. Biochim Biophys Acta (1980) 2.89
Permeability of human synovial membrane to plasma proteins. Relationship to molecular size and inflammation. Arthritis Rheum (1971) 2.13
Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol (1981) 1.86
Lipid peroxidation in rheumatoid arthritis: thiobarbituric acid-reactive material and catalytic iron salts in synovial fluid from rheumatoid patients. Clin Sci (Lond) (1984) 1.61
Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med (1988) 1.58
Reaction of glutathione with conjugated carbonyls. Z Naturforsch C (1975) 1.39
Formation of cyclic adducts of deoxyguanosine with the aldehydes trans-4-hydroxy-2-hexenal and trans-4-hydroxy-2-nonenal in vitro. Cancer Res (1986) 1.31
Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous hydroxyalkenals. Biol Chem Hoppe Seyler (1986) 1.03
Clinical associations between arthritis and liver disease. Ann Rheum Dis (1982) 0.98
Intracellular and extracellular sulphydryl levels in rheumatoid arthritis. Ann Rheum Dis (1986) 0.91
Cytotoxicities of a linoleic acid hydroperoxide and its related aliphatic aldehydes toward cultured human umbilical vein endothelial cells. Chem Biol Interact (1988) 0.88
Plasma levels of malondialdehyde, a product of cyclo-oxygenase-dependent and independent lipid peroxidation in rheumatoid arthritis: a correlation with disease activity. Prostaglandins Med (1979) 0.86
Inhibition by reactive aldehydes of superoxide anion radical production in stimulated human neutrophils. Chem Biol Interact (1985) 0.84
Effects of 4-hydroxynonenal on adenylate cyclase and 5'-nucleotidase activities in rat liver plasma membranes. Chem Biol Interact (1985) 0.83
Effect of 4-hydroxynonenal on c-myc expression. Toxicol Pathol (1987) 0.81
Effects of the lipidperoxidation product 4-hydroxynonenal and related aldehydes on proliferation and viability of cultured Ehrlich ascites tumor cells. Biochem Pharmacol (1985) 0.81
Formation of aliphatic aldehydes in rat plasma and liver due to vitamin E deficiency. Chem Pharm Bull (Tokyo) (1986) 0.81
Foot-edema induced by carbonyl compounds originating from the peroxidation of liver microsomal lipids. Biochem Pharmacol (1980) 0.80
Effect of 4-hydroxy-2,3-trans-nonenal on platelet function. Thromb Haemost (1988) 0.79
Genotoxicity and cytotoxicity of selected pyrrolizidine alkaloids, a possible alkenal metabolite of the alkaloids, and related alkenals. Toxicol Appl Pharmacol (1986) 0.79
Aliphatic aldehydes inhibit the proliferative response of human peripheral blood lymphocytes to phytohemagglutinin and alloantigens. Chem Biol Interact (1987) 0.79
Lipid peroxidation during chronic inflammation induced in rats by Freund's adjuvant: effect of vitamin E as measured by expired pentane. Res Commun Chem Pathol Pharmacol (1982) 0.78
Immune complex activation of neutrophils and enhancement of the activation by rheumatoid factor and complement. J Rheumatol (1985) 0.78
4-Hydroxynonenal: a specific indicator for canine neuronal-retinal ceroidosis. Am J Med Genet Suppl (1988) 0.78
Lipid peroxide formation in experimental inflammation. Biochem Pharmacol (1972) 0.78
Detection of 4-hydroxy-nonenal, a mediator of traumatic inflammation, in a patient with surgical trauma and in the Sephadex inflammation model. Prog Clin Biol Res (1989) 0.78
Preparation of suspensions of washed platelets from humans. Br J Haematol (1972) 4.02
Adenosine diphosphate-induced platelet aggregation in suspensions of washed rabbit platelets. Br J Haematol (1970) 2.27
Dermatopolymyositis and other connective tissue diseases: a review of 105 cases. J Rheumatol (1985) 1.71
Influence of catecholamines on nucleotide-induced platelet aggregation. Nature (1966) 1.57
Chlorination studies. I. The reaction of aqueous hypochlorous acid with cytosine. Biochem Biophys Res Commun (1972) 1.53
Enzymatic basis for platelet aggregation and release: the significance of the 'platelet atmosphere' and the relationship between platelet function and blood coagulation. Br J Haematol (1974) 1.46
Chlorination studies. II. The reaction of aqueous hypochlorous acid with alpha-amino acids and dipeptides. Biochim Biophys Acta (1973) 1.33
A prospective study of the radiological changes in the cervical spine in early rheumatoid disease. Ann Rheum Dis (1981) 1.22
Influence of apyrase on stability of suspensions of washed rabbit platelets. Proc Soc Exp Biol Med (1971) 1.12
Heparin, platelets and blood coagulation: implications for low-dose heparin prophylactic regimens in venous thrombosis. Br J Haematol (1974) 1.08
Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. Thromb Haemost (1983) 1.03
Platelet activation by circulating levels of hormones: a possible link in coronary heart disease. Thromb Res (1984) 0.99
Inhibition and reversal of platelet aggregation by methyl xanthines. Thromb Diath Haemorrh (1967) 0.99
Applications of artificial intelligence for chemical inference. 8. An approach to the computer interpretation of the high resolution mass spectra of complex molecules. Structure elucidation of estrogenic steroids. J Am Chem Soc (1972) 0.97
Effect of adenine compounds on platelet aggregation. Am J Physiol (1969) 0.96
Chlorination studies. IV. The reaction of aqueous hypochlorous acid with pyrimidine and purine bases. Biochem Biophys Res Commun (1973) 0.96
Comparison of the central nervous system activity of the aqueous and lipid extract of kava (Piper methysticum). Arch Int Pharmacodyn Ther (1990) 0.94
The effect of aggregating agents on oxidative metabolism of rabbit platelets. Biochim Biophys Acta (1971) 0.92
Metabolic studies of transient tyrosinemia in premature infants. Pediatr Res (1975) 0.88
Identification of minor metabolites of 5-fluorocytosine in man by chemical ionization gas chromatography mass spectrometry. Biomed Mass Spectrom (1981) 0.87
The influence of pH, temperature, and calcium on platelet aggregation: maintenance of environmental pH and platelet function for in vitro studies in plasma stored at 37 degrees C. Br J Haematol (1974) 0.87
Electron microscopical observations on the organization of artificial thrombi in the rabbit pulmonary artery. Br J Exp Pathol (1967) 0.87
Rheumatoid arthritis and hereditary angioedema. J Rheumatol (1988) 0.86
In vitro thrombosis and platelet aggregation in myocardial infarction. Br Med J (1966) 0.85
Arterial pathology in the Australian reptile: a comparative study. J Pathol Bacteriol (1965) 0.85
Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. Immunol Cell Biol (1998) 0.84
Evidence that colagen releases human platelet constituents by two different mechanisms. Br J Haematol (1976) 0.83
A comparison of the organisation and fate of autologous pulmonary emboli and of artificial plasma thrombi in the anterior chamber of the eye, in normocholesterolaemic rabbits. J Pathol Bacteriol (1968) 0.83
Melanoma and dietary lipids. Nutr Cancer (1987) 0.83
A chemical ionization gas chromatographic mass spectrometric assay for octopamine and tyramine in rat brain. Biomed Mass Spectrom (1981) 0.83
Etanercept in severe active rheumatoid arthritis: first Australian experience. Intern Med J (2006) 0.82
Calcium ions, drug action and platelet function. Pharmacol Ther (1982) 0.82
Analysis of some commercial preparations for migraine treatment using ion-pair high-performance liquid chromatography with addition of salts to the mobile phase. J Chromatogr (1983) 0.81
Absence of alpha-methyldopamine in rat striatum after chronic administration of d-amphetamine. Life Sci (1982) 0.80
Content of significant amounts of a cytotoxic end-product of lipid peroxidation in human semen. J Reprod Fertil (1991) 0.80
Infliximab in severe active ankylosing spondylitis with spinal ankylosis. Intern Med J (2008) 0.80
Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide. Thromb Haemost (1982) 0.80
The effect of cholesterol oxidation products on human platelet aggregation. Thromb Res (1996) 0.79
Improved detection of anti-Jo-1 antibody, a marker for myositis, using purified histidyl-tRNA synthetase. J Immunol Methods (1987) 0.79
Synergistic potentiation by epinephrine of collagen or thrombin-induced calcium mobilization in human platelets. Thromb Res (1987) 0.79
Effect of 4-hydroxy-2,3-trans-nonenal on platelet function. Thromb Haemost (1988) 0.79
Uptake into mouse brain of four compounds present in the psychoactive beverage kava. J Pharm Sci (1988) 0.79
Effect on human platelets of catecholamines at levels achieved in the circulation. Atherosclerosis (1985) 0.79
Dipyridamole inhibits the oxidative modification of low density lipoprotein. Atherosclerosis (1994) 0.78
Verapamil and collagen-induced platelet reactions--evidence for a role for intracellular calcium in platelet activation. Thromb Haemost (1983) 0.78
Collagen increases cytoplasmic free calcium in human platelets. Thromb Res (1986) 0.78
Identification of new urinary metabolites in man of quinine using methane chemical ionization gas chromatography-mass spectrometry. Xenobiotica (1981) 0.78
Identification of some human urinary metabolites of the intoxicating beverage kava. J Chromatogr (1989) 0.78
The facilitating effects of adrenaline on platelet aggregation. Prostaglandins Leukot Med (1982) 0.78
Modification of human platelet function by a diet enriched in saturated or polyunsaturated fat. Atherosclerosis (1978) 0.78
Hereditary thrombocytopathy: a familial bleeding disorder due to impaired platelet coagulant activity. Aust N Z J Med (1976) 0.78
Coagulant activity of human plasma lipoproteins from normal and hyperlipidaemic subjects. Thromb Res (1978) 0.77
Observations on the natural history of coronary artery disease. Australas Ann Med (1966) 0.77
Acute postprandial lipaemia does not influence the in vivo activity of human platelets. Thromb Res (1985) 0.77
Platelet aggregation and release by ADP and thrombin: evidence for two separate effects of ADP on platelets, involvement of fibrinogen in release, and mechanism of inhibitory action of acetylsalicylic acid. Br J Haematol (1974) 0.77
Investigation of the role of arachidonic acid in platelet function and mechanisms for suppression of prostaglandin biosynthesis. Br J Haematol (1978) 0.77
Abnormal platelet reactivity in men with premature coronary heart disease. Coron Artery Dis (1994) 0.76
The role of (E)-4-hydroxy-2-nonenal in platelet activation by low density lipoprotein and iron. Atherosclerosis (1998) 0.76
Effects of acrolein on human platelet aggregation. Chem Biol Interact (1990) 0.76
Platelet aggregation and thrombus formation in Diabetes Mellitus: an in vitro study. Pathology (1970) 0.76
Marked aortic hemosiderin deposits in a patient with hemochromatosis. Arch Pathol (1967) 0.76
The organisation and fate of autologous pulmonary emboli in hypercholesterolaemic rabbits. J Pathol Bacteriol (1968) 0.76
Stereoselective accumulation of hydroxylated metabolites of amphetamine in rat striatum and hypothalamus. Br J Pharmacol (1986) 0.75
Treatment of collagenous colitis with methotrexate. Aust N Z J Med (1996) 0.75
Cerebral venous sinus thrombosis associated with the primary antiphospholipid syndrome. Resolution with local thrombolytic therapy. Med J Aust (1995) 0.75
Autologous peripheral blood stem cell transplantation with in vivo T-cell depletion for life threatening refractory systemic lupus erythematosus. Lupus (2005) 0.75
Evidence for the mechanism by which eicosapentaenoic acid inhibits human platelet aggregation and secretion - implications for the prevention of vascular disease. Thromb Res (1979) 0.75
Etanercept treatment of renal amyloidosis complicating rheumatoid arthritis. Intern Med J (2004) 0.75
The effects of (+)-amphetamine, alpha-methyltyrosine, and alpha-methylphenylalanine on the concentrations of m-tyramine and alpha-methyl-m-tyramine in rat striatum. Br J Pharmacol (1983) 0.75
Distribution and chemical composition of the toxic skin secretions from trunkfish (family Ostraciidae). Toxicon (1988) 0.75
Gas chromatographic mass-specific investigation of dextromoramide (Palfium) metabolism in the horse. J Chromatogr (1990) 0.75
Alternatives to aspirin, derived from biological sources. Agents Actions Suppl (1977) 0.75
Platelet function in malignant hyperpyrexia. Br J Anaesth (1982) 0.75
Effects of trifluoperazine on platelet activation. Thromb Res (1985) 0.75
Relationship of blood cholesterol and apoprotein B levels to angiographically defined coronary artery disease in young males. Coron Artery Dis (1993) 0.75
Uridine and inosine: pressor nucleosides from man, rat and dog. Aust J Exp Biol Med Sci (1981) 0.75
Effect of aqueous and lipid-soluble extracts of kava on the conditioned avoidance response in rats. Arch Int Pharmacodyn Ther (1990) 0.75
Mechanism of platelet aggregation and release: their possible role in vascular injury. Perspect Nephrol Hypertens (1973) 0.75
Effect of chlordimeform and clonidine on the turnover of P-octopamine in rat hypothalamus and striatum. Life Sci (1986) 0.75
Fatty acids and in vitro platelet aggregation. Aust J Exp Biol Med Sci (1966) 0.75
In vitro thrombosis and platelet aggregation in myocardial infarction. Br Med J (1966) 0.75
In-vitro thrombosis and platelet behaviour after operation. Australas Ann Med (1967) 0.75
Effect of anethole dithiolthione on human platelet aggregation. Arzneimittelforschung (1992) 0.75
Platelet activation in haemostasis: role of thrombin and other clotting factors in platelet-collagen interaction. Haemostasis (1977) 0.75
Effects of sodium bicarbonate and sodium chloride on the elimination of etorphine in equine urine. J Anal Toxicol (1997) 0.75
Further evidence for the role of thrombin in the platelet release reaction caused by various agents, and the nature of biphasic platelet aggregation. Br J Haematol (1978) 0.75
Preoperative blood tests in prediction of postoperative deep vein thrombosis. Thromb Res (1982) 0.75
Identification by methane chemical ionization gas chromatography/mass spectrometry of the products obtained by steam distillation and aqueous acid extraction of commercial Piper methysticum. Biomed Environ Mass Spectrom (1988) 0.75
The effect of halofenate--free acid on aggregation--the release reaction, coagulant activity, and lipid metabolism of human platelets. Thromb Haemost (1977) 0.75
Spontaneous arterial lesions in the antarctic seal. Arch Pathol (1966) 0.75
Effects of clofibrate on platelets and evidence of the involvement of platelet lipids in platelet function. Thromb Res (1977) 0.75